Jan 24, 2023 9:20am EST 22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position
Jan 23, 2023 9:20am EST 22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs
Jan 18, 2023 9:25am EST 22nd Century Group (XXII) Announces U.S. Distribution Partnerships with Core-Mark and Eby-Brown
Jan 17, 2023 9:00am EST FDA's Proposed Menthol Ban Advances to Final Rule Status, Greatly Benefits 22nd Century (XXII) by Affirming the Need for VLN(R) Menthol King as a Critical Off-Ramp for Adult Menthol Smokers
Dec 13, 2022 9:25am EST 22nd Century Group (XXII) Comments on the Advancement of New Zealand's National Reduced Nicotine Content Law
Nov 16, 2022 9:25am EST 22nd Century Group’s GVB Biopharma Opens New Central Distribution Facility in The Netherlands
Nov 15, 2022 9:25am EST 22nd Century Group (Nasdaq: XXII) GVB Biopharma to Exhibit at MJBizCon in Las Vegas
Nov 14, 2022 8:19am EST 22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences
